NCT00024674View on ClinicalTrials.gov

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2001

Conditions
Neoplasms
Interventions
DRUG

SS1(dsFv)-PE38

Trial Locations (1)

20892

NCI/NIH, Bethesda

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT00024674 - Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days | Biotech Hunter | Biotech Hunter